FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
This Quarter Return
+27.44%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$203M
AUM Growth
+$203M
(+5.5%)
Cap. Flow
+$3.45M
Cap. Flow
% of AUM
1.69%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
Pharvaris
PHVS
|
$7.52M |
Top Sells
| 1 |
Quantum-Si Incorporated
QSI
|
$3.12M |
| 2 |
Lyell Immunopharma
LYEL
|
$954K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pharvaris
PHVS
$1.39B
| $56.7M | 27.86% | 3,743,450 +496,524 | +15% | +$7.52M |
|
|
2
Lyell Immunopharma
LYEL
$213M
| $30.8M | 15.17% | 9,700,000 -300,000 | -3% | -$954K |
|
|
KNTE
3
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $29.3M | 14.41% | 9,671,643 | – | – |
|
4
Aclaris Therapeutics
ACRS
$209M
| $29.1M | 14.32% | 2,808,034 | – | – |
|
5
Kura Oncology
KURA
$686M
| $19.6M | 9.62% | 1,849,947 | – | – |
|
|
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
| $19.6M | 9.62% | 1,787,094 | – | – |
|
7
Syndax Pharmaceuticals
SNDX
$1.41B
| $18.3M | 9% | 875,000 | – | – |
|
|
8
Quantum-Si Incorporated
QSI
$227M
| – | – | -1,771,249 | Closed | -$3.12M |
|